Press release
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic Bacterial Infection
According to Transparency Market Research, the U.S. bacterial conjunctivitis drugs market will be worth US$439.8 mn by 2024. This will be a decrease from the previous years as the generic variants encroach the market of bacterial conjunctivitis drugs. On the basis of drug class, the topical fluoroquinolones segment is leading in terms of demand.
Obtain Report Details @ https://www.transparencymarketresearch.com/us-bacterial-conjunctivitis-drugs-market.html
However, the demand for topical fluoroquinolones will reduce drastically on account of patent expirations of best selling drugs of this class, including, Moxeza, Vigamox, and Zymaxid. This market segment’s worth is estimated to come down to US$286.4 mn by 2024 on account of encroachment by generic variations of these drugs.
Availability of Affordable Generic Medications to Dampen Growth of Bacterial Conjunctivitis Drugs Market
The report states that the U.S. bacterial conjunctivitis drugs market is likely to experience a patent cliff in the near future. The availability of cost effective generic medicines will hamper the market for bacterial conjunctivitis drugs extensively. There is a dearth of novel compounds available for clinical and preclinical examination. There are very few investigations regarding bacterial conjunctivitis and approval of drugs in the pipeline at present. In addition to this, owing to drug expiry issue, doctors are prescribing a variety of affordable generic medications from the past few years.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12323
Ophthalmologists and optometrists generally prescribe antibiotics in the form of eye drops and ointments. All these factors are behind the decline of the U.S. bacterial conjunctivitis drugs market. In addition to all these, patients are aware that conjunctivitis is usually acute and will cure on its own in a few days, limiting the demand for bacterial conjunctivitis drugs.
Herbal Treatment May Prove Profitable
On a positive note however, the shift from pharmacological medicines to herbal treatment options will open doors for growth opportunities in the market. Manufacturers are recommended to develop herbal products for the treatment of bacterial conjunctivitis to earn profit. The growing prevalence of ophthalmic bacterial infection will also help the market’s growth. In addition to this, the susceptibility of this infection to spread among all age groups from infants to the elderly will drive the growth prospects for this market in the U.S.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12323
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic Bacterial Infection here
News-ID: 1217835 • Views: 343
More Releases from Transparency Market Research
Automotive Rear Occupant Alert System | expand at a CAGR of 13.5 % | reach US$ 2 …
The global Automotive Rear Occupant Alert System market is estimated to attain a valuation of US$ 2.1 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 13.5% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Vehicle Services Market, analysis Outlook, Trend, Growth And Share Estimation An …
The global Vehicle Services market is estimated to attain a valuation of US$ 1.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4% during the forecast period, 2022-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Automotive Tire Market analysis Industry Analysis, Opportunity Assessment And Fo …
The global Automotive Tire market is estimated to attain a valuation of US$ 209.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.4% during the forecast period, 2022-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Automotive Alloy Wheels Market analysis To Reflect Impressive Growth Rate By 203 …
The global Automotive Alloy Wheels market is estimated to attain a valuation of US$ 44.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during the forecast period, 2022-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders…
More Releases for Bacterial
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Vaginosis Drug Market is Growing Rapidly Due To Rising Awareness About …
Worldwide Market Reports added Latest Research Report titled "Global Bacterial Vaginosis Drug Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database.
In this report, the global Bacterial Vaginosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Ask For Sample Copy…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Hospital and Community Acquired Bacterial Infections Pushing Growth of Anti-Bact …
This report covers the market for major anti-bacterial drugs marketed today along with a pipeline analysis and takes the reader through 22 major drugs expected to be seen in the period between 2013 and 2019. The report analyzes marketed and approved drugs such as Cubicin, Teflaro/Zinforo, Dificid, Dalvance, Orbactiv, Sivextro, Zerbaxa, Avycaz, Zyvox, Avelox, Augmentin, Zosyn/Tazocin, Invanz and Tygacil. Along with this, it also reports analysis for other expected candidates…
